Business Wire

UPFIELD

Share
Upfield Launches World's First Plastic-free, Recyclable Tub for Its Plant Butters and Spreads

Upfield, global leader in plant-based foods, today announces the world's first plastic-free, recyclable tub for its plant butters and spreads.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240108563070/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Upfield launches world's first plastic-free, recyclable tub for its plant butters and spreads (Photo: Business Wire)

Following four years of innovation, in collaboration with Footprint, MCC and Pagès Group, this introduction marks the beginning of Upfield's transition to a paper solution across its portfolio, delivering on the company's ambition to reduce plastic content by 80% by 2030.

Initially launched in Austria with Flora Plant towards the end of 2023, Upfield expects further scaling of its paper solution, aiming to replace up to two billion plastic tubs by 2030, avoiding more than 25,000 tons of plastic waste per year.

The pioneering paper tubs were developed with Upfield’s leading Research & Development team utilising Footprint's material sciences technology. They are made from compressed wet paper fibres and are waterproof, oil-proof, and recyclable in local paper waste streams. The tub has received Conventional Plastic Free Certification and uses paper from a PEFC-certified supplier. Upfield expects the packaging to achieve home compostability certification by 2025.

David Haines, Group CEO for Upfield, commented, "As a global leader in plant-based foods, we take our responsibility to make a positive impact on the world seriously. Globally, 40% of all plastic produced is for packaging that is used once and then discarded, it is clear that the issue of plastic waste is one of the most critical facing our environment. When we established Upfield, innovating our way out of plastic tubs was our moon-shot and I am very proud of all Upfielders that continue to work towards this goal. Consumers today demand products that benefit both people and the planet. Our plant butters and spreads do exactly that. We're excited about the potential to launch this across our most iconic brands in some of our most important markets."

Unlike many paper packaging solutions, Upfield's paper tubs do not have a plastic liner so they can be recycled along with other paper and cardboard household waste, as verified by a leading European recycling company.

Karina Cerdeira, Head of Packaging for Upfield, said, "We are proud to have created, with Footprint, an innovative paper-based tub that is durable, oil-resistant and appealing and which many thought would be impossible with paper. But after years of dedicated focus from joint Upfield and Footprint R&D teams and dozens of prototypes, we made the impossible, possible. This new paper tub marks a true milestone for sustainable packaging that significantly minimises reliance on plastic. We will continue pushing boundaries through further innovation to adapt for compostability, develop new sizes and formats, and refine towards the optimal solution. We hope what we've achieved inspires other businesses to keep pursuing positive change."

Yoke Chung, Co-founder and Chief Technology & Innovation Officer for Footprint, added, "Footprint's commitment to a more sustainable planet is showcased through our partnership with Upfield. The introduction of a ground-breaking solution, in collaboration with Upfield establishes a pioneering industry standard. This marks the introduction of the first oil-resistant paper tub for plant-based spreads. We are proud to collaborate with Upfield on this transformative endeavour, as it resonates with our shared objective of assisting customers in realizing their sustainability goals. This collaborative effort underscores the transformative influence of innovation in fostering positive environmental change to shape a brighter future for everyone."

To stay up to date on the journey, follow @UpfieldGlobal on social or visit Upfield.com.

About Upfield

Upfield is a global leader in plant-based food, operating in four categories – butters and spreads, creams, liquids and cheeses. Over the last four years, Upfield has been on a journey to separate, stabilise, transform, and turn around our platform which today is unique in the plant-based space – combining scale of historical reach and scale of future growth ambition. We are built on the foundation of our power brands, which achieve high Brand Power Index versus wider consumer goods brands in all our key markets. Our brands are built upon our heritage of 150 years of knowledge of plant-based foods, deep R&D expertise, with 15 manufacturing sites across five continents and an end-to-end supply chain ensuring best service and delivery for our customers and consumers. Upfield's processes, products and people combine to create a business where our portfolio and purpose are completely aligned. www.upfield.com

About Footprint

Footprint is a global materials science and technology company with a clear vision to create a healthier planet and healthier people. Our mission is to provide solutions to eliminate single-use plastics in our food chain. Footprint's engineers use plant-based fiber technology to design, develop, and manufacture bio-based products. Footprint is rapidly expanding into new categories with customized and patented solutions for customers. While working with leading global consumer brands, Footprint's products have already led to a worldwide reduction of millions of pounds of plastic waste from entering the environment.

Footprint was founded in 2014 and employs approximately 2,000 people with operations in the U.S., Mexico, Europe, and Asia. Footprint was named to Fast Company's “Brands that Matter” list in 2022, CNBC’s “Disruptor 50” list in 2021, and Fortune’s “Change the World” list in 2020.

For more information on Footprint’s sustainable solutions, visit www.footprintus.com.

MCC Labels provides the label for the paper tub and Pagès the equipment (robot system) to apply the label.

About MCC Verstraete

MCC Verstraete has over 30 years of experience in offset-printing labels for injection molding, blow molding and thermoforming. In-depth understanding of materials, innovation and sustainability have made MCC Verstraete a world leader, producing over 60 million in mold labels every single day for numerous segments within the packaging industry. The drive for innovation recently led to 2 new product categories: next to polypropylene in mold labels, MCC Verstraete offers Molded Fiber Labeling™ and PP heat-seal die-cut lidding. MCC Verstraete has production sites in Belgium, Australia and the US. Together with MCC Korsini (Turkey) and Karydakis IML SA (Greece), MCC Verstraete forms the IML Business Unit within Multi-Color Corporation.

Visit iml.mcclabel.com/en for more information.

About Pagès Group

Pagès Group is a worldwide company with more than 40 years of expertise in decoration solutions and downstream automation for the packaging industry. The group has subsidiaries in France, in the Netherlands, the USA, Canada and China. As of today, more than 3000 automation systems have been installed in more than 45 countries. Among others, we developed Molded Fiber Labeling (MFL™), a world premiere decoration technology to decorate fiber molded containers for a sustainable and stunning packaging. To learn more about Pagès Group automation solutions, please visit www.pagesgroup.net or follow us on LinkedIn.

About EMSUR

EMSUR is the business unit of Grupo Lantero that provides flexible packaging solutions mainly for the food and beverage sector, home and personal care products, with lamination and printing in both rotogravure and flexography.

It currently has production sites in Europe and America, which allows to develop its activity in more than 80 countries across America, Europe, Africa and Asia. Emsur produces almost 600 million square metres of sleeves, lids, banners, labels, die-cuts, pouches and other flexible products per year.

Innovation, developed through the Innotech team and facilities, is one of their key pillars. Visit www.emsur.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240108563070/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable

GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release

Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus

Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye